E-nitiate Biopharmaceuticals
About:
E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research.
Website: http://www.enitiatebio.com/en.php/
Top Investors: TaiKun Fund, LPSCO, Hangzhou Jintou Industrial Fund, Betta Pharmaceuticals
Description:
E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.
Total Funding Amount:
$17.3M
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2020-01-01
Contact Email:
qiyuanshengwu(AT)enitiatebio.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2022-09-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai